Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 6/20 | 0.80 |
| ▸ | MMP9 | P14780 | 6/20 | 0.80 |
| ▸ | MMP3 | P08254 | 3/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.68 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | APEX1 | P27695 | 1/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | MMP13 | P45452 | 2/20 | 0.53 |
| ▸ | MMP8 | P22894 | 1/20 | 0.50 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | HRH1 | P35367 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenobarbital SCHEMBL18825042 | 1.00 | MMP2 (0.80) | MMP2MMP9MMP3KMT2AMEN1 | |
| Phenobarbital SCHEMBL28099657 | 1.00 | MMP2 (0.80) | MMP2MMP9MMP3KMT2AMEN1 | |
| Phenobarbital SCHEMBL2592325 | 1.00 | MMP2 (0.80) | MMP2MMP9MMP3KMT2AMEN1 | |
| Phenobarbital SCHEMBL3475428 | 0.98 | MMP2 (0.77) | MMP2MMP9MMP3KMT2AMEN1 | |
| Phenobarbital SCHEMBL22032658 | 0.98 | MMP2 (0.77) | MMP2MMP9MMP3KMT2AMEN1 | |
| Phenobarbital SCHEMBL4193755 | 0.98 | MMP2 (0.77) | MMP2MMP9MMP3KMT2AMEN1 | |
| Phenobarbital SCHEMBL1322895 | 0.98 | MMP2 (0.77) | MMP2MMP9MMP3KMT2AMEN1 | |
| Phenobarbital SCHEMBL352763 | 0.98 | MMP2 (0.77) | MMP2MMP9MMP3KMT2AMEN1 | |
| Phenobarbital SCHEMBL6807467 | 0.98 | MMP2 (0.77) | MMP2MMP9MMP3KMT2AMEN1 | |
| Phenobarbital SCHEMBL2120028 | 0.98 | MMP2 (0.77) | MMP2MMP9MMP3KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 174804 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3607938-B1 | PHARMACEUTICAL COMPOSITION | SOVIC BRKICIC LJILJANA (HR) | 2026-05-27 | — | — | EP | claimed |
| US-12636254-B2 | Stabilization of phenobarbital sodium for injection | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) | 2026-05-26 | — | — | US | claimed |
| WO-2026102486-A1 | METHOD FOR PRODUCING LOW ALCOHOL OR REDUCED ALCOHOL BEVERAGES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2026-05-21 | — | — | WO | claimed |
| US-20260137654-A1 | COMPOUNDS AND METHODS FOR TREATING AN EPILEPTIC DISORDER | THE REGENTS OF THE UNIV OF CALIFORNIA (US) | 2026-05-21 | — | — | US | claimed |
| US-12629377-B2 | Lamotrigine oral liquid suspension and use thereof | ROWP IP HOLDING II LLC | 2026-05-19 | — | — | US | claimed |
| CN-122055161-A | Microbiota Restoration Therapy (MRT) compositions and methods of administration | 辉凌微生物组有限公司 | 2026-05-15 | — | — | CN | claimed |
| WO-2026099508-A1 | METHOD FOR PRODUCING A TRYPSIN-LIKE PROTEASE IN BACILLUS | KERRY GROUP SERVICES INTERNATIONAL LTD (IE) | 2026-05-15 | — | — | WO | claimed |
| WO-2026102415-A1 | MICROBIAL BIOMARKERS OF CANINE IDIOPATHIC EPILEPSY | MARS, INCORPORATED (US) | 2026-05-15 | — | — | WO | claimed |
| EP-4741416-A1 | METHOD FOR PRODUCING A TRYPSIN-LIKE PROTEASE IN BACILLUS | Kerry Group Services International Ltd (IE) | 2026-05-13 | — | — | EP | claimed |
| US-20260124211-A1 | COMPOSITION CONTAINING LAMOTRIGINE, AND PREPARATION METHOD AND USE THEREOF | SHANGHAI AUCTA PHARMACEUTICALS CO., LTD. (CN) | 2026-05-07 | — | — | US | claimed |
| US-4132753-A | Process for preparing oral sustained release granules | AMERICAN CYANAMID COMPANY (US) | 1979-01-02 | — | — | US | claimed |
| US-4126684-A | 4-AMINO-3-P-HALOPHENYLBUTYRIC ACIDS AND THEIR DERIVATIVES USED IN THE CONTROL OF NARCOTIC ABUSE | CIBA-GEIGY CORPORATION (US) | 1978-11-21 | — | — | US | claimed |
| US-4107153-A | Heat-resistant thermosetting polyimide resin | TOSHIBA CHEMICAL PRODUCTS CO., LTD. (JP) | 1978-08-15 | — | — | US | claimed |
| US-4107288-A | CROSSLINKED MATRIX OF NATURAL POLYMERS, ALDEHYDE HARDENING AGENT, SOLVATING | PHARMACEUTICAL SOCIETY OF VICTORIA (AU) | 1978-08-15 | — | — | US | claimed |
| US-4036823-A | Barbituric acid antigenic conjugates, their preparation, antibodies and use | BIOLOGICAL DEVELOPMENTS, INC. (US) | 1977-07-19 | — | — | US | claimed |
| US-4029662-A | Method of making barbituric acid derivatives | BRISTOL-MYERS COMPANY (US) | 1977-06-14 | — | — | US | claimed |
| US-4012498-A | Sustained release tablet formulations | SANDOZ, INC. (US) | 1977-03-15 | — | — | US | claimed |
| US-3995021-A | DIAZOTIZATION OF AN AMINO PHENYL SUBSTITUTED HAPTEN | BIOLOGICAL DEVELOPMENTS, INC. (US) | 1976-11-30 | — | — | US | claimed |
| US-3957995-A | ADMINISTERING, CEREBRAL VASODILATOR ACTIVITY | PARCOR (FR) | 1976-05-18 | — | — | US | claimed |
| US-3947443-A | Process for preparing 1,3-bis(halomethyl)phenobarbitals | THE KENDALL COMPANY (US) | 1976-03-30 | — | — | US | claimed |